SlideShare a Scribd company logo
• There is a outbreak of endopthalmitis in
patients undergone surgery in the camp held
by District hospital
• how will you investigate?
• Which study design will you used investigate?
Study designs
Quantitative
Observational
Descriptive
Case report
Case series
Cross sectional
longitudinal
Experimental
Analytical
Case control
cohort
Cross sectional
Qualitative
Field
expt Clinical
trial
Community
trial
Case Control Study
Dr Suvarna Joshi
Case Control Study
Dr Suvarna Joshi
Associate Professor Microbiology
Grant Govt Medical College & JJ group
of hospitals Mumbai
SLO
• Indications
• Layouts of typical case control study
• Steps
• Interpretation of odds ratio & other statistics
emerging out of case control study
• Possible biases and their resolution
• Comparison with cohort studies
Indications
• Investigating outbreak
• Evaluating effectiveness of new vaccine
• Evaluation of treatment & program efficacy
• Genetic epidemiology
• Occupational health research
• Evaluation of screening
• Outbreak investigations
Case Control study design
General characteristics
• Observational epidemiological study
• Analytical type
• Testing hype
• Hypothesis – association type
• Two groups-case , control
• Retrospective –
going back from outcome(disease) to exposure
• Also called Flashback study
Steps
• Sample size estimation
• Selection of cases
• Control matching
• Collection of data
• Applying statistics
Selection of cases
Definition of cases
• Individuals with the disease entity under
investigation (as per standard definition)
• Based on standard diagnostic criteria
• These criteria should be
objective, valid, reproducible
Selection of Cases
• Source-
Hospital , workplace, community/general
population
Time (eligibility)-
New cases- incident cases within specified
time
Old cases- prevalent cases -derived from
cross sectional survey
Selection usually done from the available cases
Selection of controls
• Control- One who does not have disease
under investigation
• Need not be healthy
• Control and cases should be from same study
base(source) if cases selected from hospital
then controls also from same hospital
Sources for Control
• Hospital, relatives, neighbors, occupational
associates, general population
d) Neighbors
(i) walk (door to door)
(ii) Phone (random digit dialing)
(iii) Letter carrier routes
e) Friends or associates of cases
f) Siblings, spouses or other relatives
g) Other
Matching
• Done for confounding factors to ensure the
comparability
• Eg age, sex, occupation, education, social
status
• Individual/frequency matching
• Overmatching: do not match for risk factor
under study
• Increase power of study; increasing no. of
controls per case
Matching…
• Control >4 per case will just increase the cost
• Disadvantage of matching
• Time consuming
• Costly
• Exact match may not be found
• Multiple controls per case
• (one from hospital and one from general
population per case)
Bias
• Recall bias
Selection bias
Information bias
Non-response bias
Analysis bias
Recall bias
• eg A case control study on adults which
gathered information relating to
hospitalization prior to the age of 16 was
concerned about poor recall
• Recall bias (cases may remember
their exposure with a higher or
lower accuracy than controls do)
Overcoming recall bias
• In subsample of both cases and controls,
medical records were examined to determine
evidence of for difference in recall between
cases and control
Selection bias
• Case control study on duodenal ulcer and
smoking
• Cases- patients attending gastroenterology
clinic (likely to be severe cases)
• Any risk factor derived from those cases may
represent risk factors for severity rather than
ulcer susceptibility per se
• Referal practice
Information/interviewer’s bias
• Case control study on possible link between
febrile illness and subsequent early pregnancy
loss
• Greater care in introducing questions to the case
mothers, the study coordinator was concerned
that the interviewer might have probed more
closely for history of fever in the cases
• It was found that interviewer was taking 10 min
more than normal pregnant controls
Case Control Design
Time
Direction of Inquiry
Population
Cases with
the Disease
Controls without
the disease
Exposed
Exposed
Not Exposed
Not Exposed
Case-Control Studies: Methodology
Then measure,
post-exposure
First Select the Cases
and Controls
Cases
(with
disease)
Control
(without
disease)
Were Exposed A B
Not Exposed C D
A+C B+D
Population
Exposed
A/A+C B./B+D
Figure 1 (continued)
a
c ad
Odds Ratio = =
b bc
d
Risk = a
a + b
= c
c + d
a b
c d
Case Control
E+
E-
Kidney stone
present
Kidney stone
absent
Total
Drinking hard
water
90 (a) 20 (b) 110
Not drinking
hard water
10 (c) 80 (d) 90
total 100 100 200
Exposure rate in cases = a/a+c = 90/90+10= 90%
Exposure rate in control = b/+d= 20/20+80= 20%
Odds ratio= ad/bc = 90x80/20x10=7200/200=36
• Odd ‘s ratio =1 no association
• > 1 positive association
• < 1 protective effect
Strength of Association
Relative Risk;(Prevalence); Odds Ratio Strength of Association
0.83-1.00 1.0-1.2 None
0.67-0.83 1.2-1.5 Weak
0.33-0.67 1.5-3.0 Moderate
0.10-0.33 3.0-10.00 Strong
<0.01 >10.0 Approaching
Infinity
Nested Case-Control Studies
Figure 3
Study Population
TIME 1
YEARS
TIME 2
Develop
Disease
Do Not
Develop
Disease
CASES CONTROLS
CASE-CONTROL STUDY
Obtain
interviews,
bloods,
urines, etc.
A. Advantages of Nested Case-Control Studies
1. Possibility of recall bias is eliminated, since data
on exposure are obtained before disease
develops.
2. Exposure data are more likely to represent the
pre-illness state since they are obtained years
before clinical illness is diagnosed.
3. Costs are reduced compared to those of a
prospective study, since laboratory tests need to
be done only on specimens from subjects who
are later chosen as cases or as controls.
• A major limitation of cross-sectional surveys
and case-control studies is difficulty in
determining if exposure or risk factor
preceded the disease or outcome.
to overcome this problem ?
Cohort study
WHAT IS COHORT
• Ancient Roman military
unit, A band of warriors.
• Persons banded
together.
• Group of persons with a
common statistical
characteristic. [Latin]
• E.g. age, birth date,
Indication
• When a good evidence of association between
exposure and disease
• When exposure is rare but incidence of
disease in exposed is high
• When follow up is easy and cohort is relatively
stable
• Ample funds available
Elements of cohort study
• Selection of study subjects
• Obtaining data on exposure
• Selection of comparison group
• Follow up
• Analysis
Selection of subject
• Group of people exposed to suspected cause
• Eg cohort group who drink hard water (study
cohort)
• And cohort who don’t drink hard
water(control cohort)
• Comparison group are in built based on
gradation of exposure
• Cohort must be free from disease under study
• Both cohort should be equally susceptible to
the disease under study
• Both cohort should be comparable
• Diagnostic & eligibility criteria must be
defined before study commences
Characteristic of Cohort study
 Longitudinal
 Prospective studies
 Forward looking study
 Incidence study
 starts with people free of disease
 assesses exposure at “baseline”
 assesses disease status at “follow-up”
b+d
Frame work of Cohort studies
c
c+d
a
a+b
Total Yes
Disease Status
Yes
No
Exposure
Status
b
d
a+c
N
No
Study
cohort
Comparison
cohort
Selection of study subjects
• General population
– Whole population in an area
– A representative sample
• Special group of population
– Select group
• occupation group / professional group (Dolls study )
– Exposure groups
• Person having exposure to some physical, chemical or biological
agent
– e.g. X-ray exposure to radiologists
Obtaining data on exposure
• Personal interviews / mailed questionnaire
• Reviews of records
– Dose of drug, radiation, type of surgery etc
• Medical examination or special test
– Blood pressure, serum cholesterol
• Environmental survey
• By obtaining the data of exposure we can classify
cohorts as
– Exposed and non exposed and
– By degree exposure we can sub classify cohorts
Selection of comparison group
• Internal comparison
– Only one cohort involved in study
– Sub classified and internal comparison done
• External comparison
– More than one cohort in the study for the purpose of
comparison
– e.g. Cohort of radiologist compared with ophthalmologists
• Comparison with general population rates
– If no comparison group is available we can compare the
rates of study cohort with general population.
– Cancer rate of uranium miners with cancer in general
population
Follow-up
• To obtain data about outcome to be determined
(morbidity or death)
– Mailed questionnaire, telephone calls, personal interviews
– Periodic medical examination
– Reviewing records
– Surveillance of death records
– Follow up is the most critical part of the study
• Some loss to follow up is inevitable due to death
change of address, migration, change of occupation.
• Loss to follow-up is one of the draw-back of the
cohort study.
ANALYSIS
• Calculation of incidence rates among exposed
and non exposed groups
• Estimation of risk
Incidence rates of outcome
N
d
c
b
a
Yes No
Disease Status
Yes
No
Exposure
Status
a+b
c+d
b+d
a+c
Total
Study
cohort
Comparison
cohort
Incidence rate
• Incidence among exposed =
a
a+b
• Incidence among non-exposed =
c
c+d
Estimation of risk
• Relative Risk
incidence of disease among exposed
RR = ______________________________
Incidence of disease among non-exposed
a/a+b
= _________
c/c+d
Estimation of Risk
• Attributable Risk
Incidence of disease among exposed –
incidence of disease among non exposed
AR = _______________________________
Incidence of disease among exposed
a/a+b – c/c+d
AR = _______________
a/a+b
Smoking Lung cancer Total
YES NO
YES 70 6930 7000
NO 3 2997 3000
73 9927 10000
Find out RR and AR for above data
• Incidence of lung cancer among smokers
70/7000 = 10 per 1000
• Incidence of lung cancer among non-smokers
3/3000 = 1 per thousand
RR = 10 / 1 = 10
(lung cancer is 10 times more common among
smokers than non smokers)
AR = 10 – 1 / 10 X 100
= 90 %
(90% of the cases of lung cancer among smokers are
attributed to their habit of smoking)
Types of Cohort Study
• Prospective cohort study
• Retrospective (historical) cohort study
• Combination of Retrospective and Prospective
cohort study.
Cohort studies
Strengths
• We can find out
incidence rate and risk
• More than one disease
related to single
exposure
• can establish cause -
effect
• good when exposure is
rare
• minimizes selection and
information bias
Weaknesses
• losses to follow-up
• often requires large
sample
• ineffective for rare
diseases
• long time to complete
• expensive
• Ethical issues
Comparison between Case control & Cohort
Case control
• Proceed from effect to
cause
• Involves few subjects
,quick ,less expensive
• Yields only estimate of
relative risk by virtue of
odds ratio
• Sampling bias
• Measuremnet bias
Cohort
• Proceed from cause to
effect
• Involves large no. prolong
duration, expensive
• Yield incidence
rate,relative risk,
attributable risk
• No sampling bias
• No information bias
Thank U

More Related Content

Similar to Case control studies.ppt

Case Control Study.pptx
Case Control Study.pptxCase Control Study.pptx
Case Control Study.pptx
Mostaque Ahmed
 
Types of study design
Types of study designTypes of study design
Types of study design
Dipayan Banerjee
 
Random Clinical Trials
Random Clinical Trials Random Clinical Trials
Random Clinical Trials
Zaina Assaf
 
Case_Control_Study.pptx
Case_Control_Study.pptxCase_Control_Study.pptx
Case_Control_Study.pptx
Royal Dental College Library
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
jarati
 
Cohort study
Cohort study Cohort study
Cohort study
soudfaiza
 
Research Designs
Research DesignsResearch Designs
Research Designs
Aravind L R
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
Kayode Afolabi
 
Epidemiological study designs Part - I.pptx
Epidemiological study designs Part - I.pptxEpidemiological study designs Part - I.pptx
Epidemiological study designs Part - I.pptx
IsaacLalrawngbawla1
 
Cohort study and case control study
Cohort study and case control studyCohort study and case control study
Cohort study and case control study
Niv09
 
Chapter 34 medical stat
Chapter 34 medical statChapter 34 medical stat
Chapter 34 medical stat
Nilesh Kucha
 
STUDY DESIGNS.ppt
STUDY DESIGNS.pptSTUDY DESIGNS.ppt
STUDY DESIGNS.ppt
Mkindi Mkindi
 
Case Control Studies
Case Control StudiesCase Control Studies
Case Control Studies
Pegasoftcorp1
 
Cohort Study Design- Research Methodology
Cohort Study Design- Research MethodologyCohort Study Design- Research Methodology
Cohort Study Design- Research Methodology
y6r8gs9swp
 
2-Epidemiological studies
2-Epidemiological studies2-Epidemiological studies
2-Epidemiological studies
ResearchGuru
 
screening.pptx
screening.pptxscreening.pptx
screening.pptx
JazeelaMohamedSiddiq
 
Types of studies 2016
Types of studies 2016Types of studies 2016
Types of studies 2016
Ahmed Elfaitury
 
Analytic upto surviellance
Analytic upto surviellanceAnalytic upto surviellance
Analytic upto surviellance
kaleabtegegne
 
Research Methods 2 for Midwifery students .pptx
Research Methods 2 for Midwifery students .pptxResearch Methods 2 for Midwifery students .pptx
Research Methods 2 for Midwifery students .pptx
Endex Tam
 
Chapter 3 epidemiologic study design2008
Chapter 3 epidemiologic study design2008Chapter 3 epidemiologic study design2008
Chapter 3 epidemiologic study design2008
drtaa62
 

Similar to Case control studies.ppt (20)

Case Control Study.pptx
Case Control Study.pptxCase Control Study.pptx
Case Control Study.pptx
 
Types of study design
Types of study designTypes of study design
Types of study design
 
Random Clinical Trials
Random Clinical Trials Random Clinical Trials
Random Clinical Trials
 
Case_Control_Study.pptx
Case_Control_Study.pptxCase_Control_Study.pptx
Case_Control_Study.pptx
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
 
Cohort study
Cohort study Cohort study
Cohort study
 
Research Designs
Research DesignsResearch Designs
Research Designs
 
Epidemiological study designs
Epidemiological study designsEpidemiological study designs
Epidemiological study designs
 
Epidemiological study designs Part - I.pptx
Epidemiological study designs Part - I.pptxEpidemiological study designs Part - I.pptx
Epidemiological study designs Part - I.pptx
 
Cohort study and case control study
Cohort study and case control studyCohort study and case control study
Cohort study and case control study
 
Chapter 34 medical stat
Chapter 34 medical statChapter 34 medical stat
Chapter 34 medical stat
 
STUDY DESIGNS.ppt
STUDY DESIGNS.pptSTUDY DESIGNS.ppt
STUDY DESIGNS.ppt
 
Case Control Studies
Case Control StudiesCase Control Studies
Case Control Studies
 
Cohort Study Design- Research Methodology
Cohort Study Design- Research MethodologyCohort Study Design- Research Methodology
Cohort Study Design- Research Methodology
 
2-Epidemiological studies
2-Epidemiological studies2-Epidemiological studies
2-Epidemiological studies
 
screening.pptx
screening.pptxscreening.pptx
screening.pptx
 
Types of studies 2016
Types of studies 2016Types of studies 2016
Types of studies 2016
 
Analytic upto surviellance
Analytic upto surviellanceAnalytic upto surviellance
Analytic upto surviellance
 
Research Methods 2 for Midwifery students .pptx
Research Methods 2 for Midwifery students .pptxResearch Methods 2 for Midwifery students .pptx
Research Methods 2 for Midwifery students .pptx
 
Chapter 3 epidemiologic study design2008
Chapter 3 epidemiologic study design2008Chapter 3 epidemiologic study design2008
Chapter 3 epidemiologic study design2008
 

More from Rahul Netragaonkar

HISTORY OF MEDICINE.ppt
HISTORY OF MEDICINE.pptHISTORY OF MEDICINE.ppt
HISTORY OF MEDICINE.ppt
Rahul Netragaonkar
 
commu-ppt.ppt
commu-ppt.pptcommu-ppt.ppt
commu-ppt.ppt
Rahul Netragaonkar
 
CHICKENPOX AND MEASLES.ppt
CHICKENPOX AND MEASLES.pptCHICKENPOX AND MEASLES.ppt
CHICKENPOX AND MEASLES.ppt
Rahul Netragaonkar
 
Foundation Of Communication.pptx
Foundation Of Communication.pptxFoundation Of Communication.pptx
Foundation Of Communication.pptx
Rahul Netragaonkar
 
Influenza, Bird Flu, SARS & Swine Flu.pptx
Influenza, Bird Flu, SARS & Swine Flu.pptxInfluenza, Bird Flu, SARS & Swine Flu.pptx
Influenza, Bird Flu, SARS & Swine Flu.pptx
Rahul Netragaonkar
 
Cholera updated.pptx
Cholera updated.pptxCholera updated.pptx
Cholera updated.pptx
Rahul Netragaonkar
 
cholera.ppt
cholera.pptcholera.ppt
cholera.ppt
Rahul Netragaonkar
 
Diabetes- Prevention & Lifestyle Modifications.pptx
Diabetes- Prevention & Lifestyle Modifications.pptxDiabetes- Prevention & Lifestyle Modifications.pptx
Diabetes- Prevention & Lifestyle Modifications.pptx
Rahul Netragaonkar
 
Descriptive Studies.pptx
Descriptive Studies.pptxDescriptive Studies.pptx
Descriptive Studies.pptx
Rahul Netragaonkar
 
Cholera updated.pptx
Cholera updated.pptxCholera updated.pptx
Cholera updated.pptx
Rahul Netragaonkar
 
Dengue Fever.ppt
Dengue Fever.pptDengue Fever.ppt
Dengue Fever.ppt
Rahul Netragaonkar
 
Cholera ppt.ppt
Cholera ppt.pptCholera ppt.ppt
Cholera ppt.ppt
Rahul Netragaonkar
 
C05 P08 INFLUENZA.ppt
C05 P08 INFLUENZA.pptC05 P08 INFLUENZA.ppt
C05 P08 INFLUENZA.ppt
Rahul Netragaonkar
 
cancer-ppt.pptx
cancer-ppt.pptxcancer-ppt.pptx
cancer-ppt.pptx
Rahul Netragaonkar
 
swine-flu-and-bird-flu-180616112123.pptx
swine-flu-and-bird-flu-180616112123.pptxswine-flu-and-bird-flu-180616112123.pptx
swine-flu-and-bird-flu-180616112123.pptx
Rahul Netragaonkar
 
Cancer.pptx
Cancer.pptxCancer.pptx
Cancer.pptx
Rahul Netragaonkar
 
Mumps & Rubella.pptx
Mumps & Rubella.pptxMumps & Rubella.pptx
Mumps & Rubella.pptx
Rahul Netragaonkar
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
Rahul Netragaonkar
 
ARI & Influenza.pptx
ARI & Influenza.pptxARI & Influenza.pptx
ARI & Influenza.pptx
Rahul Netragaonkar
 
Epidemiological study and designs.pptx
Epidemiological study and designs.pptxEpidemiological study and designs.pptx
Epidemiological study and designs.pptx
Rahul Netragaonkar
 

More from Rahul Netragaonkar (20)

HISTORY OF MEDICINE.ppt
HISTORY OF MEDICINE.pptHISTORY OF MEDICINE.ppt
HISTORY OF MEDICINE.ppt
 
commu-ppt.ppt
commu-ppt.pptcommu-ppt.ppt
commu-ppt.ppt
 
CHICKENPOX AND MEASLES.ppt
CHICKENPOX AND MEASLES.pptCHICKENPOX AND MEASLES.ppt
CHICKENPOX AND MEASLES.ppt
 
Foundation Of Communication.pptx
Foundation Of Communication.pptxFoundation Of Communication.pptx
Foundation Of Communication.pptx
 
Influenza, Bird Flu, SARS & Swine Flu.pptx
Influenza, Bird Flu, SARS & Swine Flu.pptxInfluenza, Bird Flu, SARS & Swine Flu.pptx
Influenza, Bird Flu, SARS & Swine Flu.pptx
 
Cholera updated.pptx
Cholera updated.pptxCholera updated.pptx
Cholera updated.pptx
 
cholera.ppt
cholera.pptcholera.ppt
cholera.ppt
 
Diabetes- Prevention & Lifestyle Modifications.pptx
Diabetes- Prevention & Lifestyle Modifications.pptxDiabetes- Prevention & Lifestyle Modifications.pptx
Diabetes- Prevention & Lifestyle Modifications.pptx
 
Descriptive Studies.pptx
Descriptive Studies.pptxDescriptive Studies.pptx
Descriptive Studies.pptx
 
Cholera updated.pptx
Cholera updated.pptxCholera updated.pptx
Cholera updated.pptx
 
Dengue Fever.ppt
Dengue Fever.pptDengue Fever.ppt
Dengue Fever.ppt
 
Cholera ppt.ppt
Cholera ppt.pptCholera ppt.ppt
Cholera ppt.ppt
 
C05 P08 INFLUENZA.ppt
C05 P08 INFLUENZA.pptC05 P08 INFLUENZA.ppt
C05 P08 INFLUENZA.ppt
 
cancer-ppt.pptx
cancer-ppt.pptxcancer-ppt.pptx
cancer-ppt.pptx
 
swine-flu-and-bird-flu-180616112123.pptx
swine-flu-and-bird-flu-180616112123.pptxswine-flu-and-bird-flu-180616112123.pptx
swine-flu-and-bird-flu-180616112123.pptx
 
Cancer.pptx
Cancer.pptxCancer.pptx
Cancer.pptx
 
Mumps & Rubella.pptx
Mumps & Rubella.pptxMumps & Rubella.pptx
Mumps & Rubella.pptx
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
 
ARI & Influenza.pptx
ARI & Influenza.pptxARI & Influenza.pptx
ARI & Influenza.pptx
 
Epidemiological study and designs.pptx
Epidemiological study and designs.pptxEpidemiological study and designs.pptx
Epidemiological study and designs.pptx
 

Recently uploaded

Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
biomechanics of running. Dr.dhwani.pptx
biomechanics of running.   Dr.dhwani.pptxbiomechanics of running.   Dr.dhwani.pptx
biomechanics of running. Dr.dhwani.pptx
Dr. Dhwani kawedia
 
District Residency Programme (DRP) for PGs in India.pptx
District Residency Programme (DRP) for PGs in India.pptxDistrict Residency Programme (DRP) for PGs in India.pptx
District Residency Programme (DRP) for PGs in India.pptx
CommunityMedicine46
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
KerlynIgnacio
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
13. PROM premature rupture of membranes
13.  PROM premature rupture of membranes13.  PROM premature rupture of membranes
13. PROM premature rupture of membranes
TigistuMelak
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
DrGirishJHoogar
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
Gokuldas Hospital
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
PGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s PerspectivePGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s Perspective
Golden Helix
 
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
Université de Montréal
 
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and SynonymsGiloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and Synonyms
Planet Ayurveda
 
Local anesthetics 2024/ Medicinal Chemistry pdf
Local anesthetics 2024/ Medicinal Chemistry pdfLocal anesthetics 2024/ Medicinal Chemistry pdf
Local anesthetics 2024/ Medicinal Chemistry pdf
NarminHamaaminHussen
 
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
Jim Jacob Roy
 
What is Obesity? How to overcome Obesity?
What is Obesity? How to overcome Obesity?What is Obesity? How to overcome Obesity?
What is Obesity? How to overcome Obesity?
Healthmedsrx.com
 
Introduction to British pharmacopeia.pptx
Introduction to British pharmacopeia.pptxIntroduction to British pharmacopeia.pptx
Introduction to British pharmacopeia.pptx
taiba qazi
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
MuhammadMuneer49
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 

Recently uploaded (20)

Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
biomechanics of running. Dr.dhwani.pptx
biomechanics of running.   Dr.dhwani.pptxbiomechanics of running.   Dr.dhwani.pptx
biomechanics of running. Dr.dhwani.pptx
 
District Residency Programme (DRP) for PGs in India.pptx
District Residency Programme (DRP) for PGs in India.pptxDistrict Residency Programme (DRP) for PGs in India.pptx
District Residency Programme (DRP) for PGs in India.pptx
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
13. PROM premature rupture of membranes
13.  PROM premature rupture of membranes13.  PROM premature rupture of membranes
13. PROM premature rupture of membranes
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
PGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s PerspectivePGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s Perspective
 
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
 
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and SynonymsGiloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and Synonyms
 
Local anesthetics 2024/ Medicinal Chemistry pdf
Local anesthetics 2024/ Medicinal Chemistry pdfLocal anesthetics 2024/ Medicinal Chemistry pdf
Local anesthetics 2024/ Medicinal Chemistry pdf
 
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
 
What is Obesity? How to overcome Obesity?
What is Obesity? How to overcome Obesity?What is Obesity? How to overcome Obesity?
What is Obesity? How to overcome Obesity?
 
Introduction to British pharmacopeia.pptx
Introduction to British pharmacopeia.pptxIntroduction to British pharmacopeia.pptx
Introduction to British pharmacopeia.pptx
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 

Case control studies.ppt

  • 1. • There is a outbreak of endopthalmitis in patients undergone surgery in the camp held by District hospital • how will you investigate? • Which study design will you used investigate?
  • 2. Study designs Quantitative Observational Descriptive Case report Case series Cross sectional longitudinal Experimental Analytical Case control cohort Cross sectional Qualitative Field expt Clinical trial Community trial
  • 3. Case Control Study Dr Suvarna Joshi
  • 4. Case Control Study Dr Suvarna Joshi Associate Professor Microbiology Grant Govt Medical College & JJ group of hospitals Mumbai
  • 5. SLO • Indications • Layouts of typical case control study • Steps • Interpretation of odds ratio & other statistics emerging out of case control study • Possible biases and their resolution • Comparison with cohort studies
  • 6. Indications • Investigating outbreak • Evaluating effectiveness of new vaccine • Evaluation of treatment & program efficacy • Genetic epidemiology • Occupational health research • Evaluation of screening • Outbreak investigations
  • 8. General characteristics • Observational epidemiological study • Analytical type • Testing hype • Hypothesis – association type • Two groups-case , control • Retrospective – going back from outcome(disease) to exposure • Also called Flashback study
  • 9. Steps • Sample size estimation • Selection of cases • Control matching • Collection of data • Applying statistics
  • 10. Selection of cases Definition of cases • Individuals with the disease entity under investigation (as per standard definition) • Based on standard diagnostic criteria • These criteria should be objective, valid, reproducible
  • 11. Selection of Cases • Source- Hospital , workplace, community/general population Time (eligibility)- New cases- incident cases within specified time Old cases- prevalent cases -derived from cross sectional survey Selection usually done from the available cases
  • 12. Selection of controls • Control- One who does not have disease under investigation • Need not be healthy • Control and cases should be from same study base(source) if cases selected from hospital then controls also from same hospital
  • 13. Sources for Control • Hospital, relatives, neighbors, occupational associates, general population d) Neighbors (i) walk (door to door) (ii) Phone (random digit dialing) (iii) Letter carrier routes e) Friends or associates of cases f) Siblings, spouses or other relatives g) Other
  • 14. Matching • Done for confounding factors to ensure the comparability • Eg age, sex, occupation, education, social status • Individual/frequency matching • Overmatching: do not match for risk factor under study • Increase power of study; increasing no. of controls per case
  • 15. Matching… • Control >4 per case will just increase the cost • Disadvantage of matching • Time consuming • Costly • Exact match may not be found • Multiple controls per case • (one from hospital and one from general population per case)
  • 16. Bias • Recall bias Selection bias Information bias Non-response bias Analysis bias
  • 17. Recall bias • eg A case control study on adults which gathered information relating to hospitalization prior to the age of 16 was concerned about poor recall • Recall bias (cases may remember their exposure with a higher or lower accuracy than controls do)
  • 18. Overcoming recall bias • In subsample of both cases and controls, medical records were examined to determine evidence of for difference in recall between cases and control
  • 19. Selection bias • Case control study on duodenal ulcer and smoking • Cases- patients attending gastroenterology clinic (likely to be severe cases) • Any risk factor derived from those cases may represent risk factors for severity rather than ulcer susceptibility per se • Referal practice
  • 20. Information/interviewer’s bias • Case control study on possible link between febrile illness and subsequent early pregnancy loss • Greater care in introducing questions to the case mothers, the study coordinator was concerned that the interviewer might have probed more closely for history of fever in the cases • It was found that interviewer was taking 10 min more than normal pregnant controls
  • 21. Case Control Design Time Direction of Inquiry Population Cases with the Disease Controls without the disease Exposed Exposed Not Exposed Not Exposed
  • 22. Case-Control Studies: Methodology Then measure, post-exposure First Select the Cases and Controls Cases (with disease) Control (without disease) Were Exposed A B Not Exposed C D A+C B+D Population Exposed A/A+C B./B+D
  • 23. Figure 1 (continued) a c ad Odds Ratio = = b bc d Risk = a a + b = c c + d a b c d Case Control E+ E-
  • 24. Kidney stone present Kidney stone absent Total Drinking hard water 90 (a) 20 (b) 110 Not drinking hard water 10 (c) 80 (d) 90 total 100 100 200 Exposure rate in cases = a/a+c = 90/90+10= 90% Exposure rate in control = b/+d= 20/20+80= 20% Odds ratio= ad/bc = 90x80/20x10=7200/200=36
  • 25. • Odd ‘s ratio =1 no association • > 1 positive association • < 1 protective effect
  • 26. Strength of Association Relative Risk;(Prevalence); Odds Ratio Strength of Association 0.83-1.00 1.0-1.2 None 0.67-0.83 1.2-1.5 Weak 0.33-0.67 1.5-3.0 Moderate 0.10-0.33 3.0-10.00 Strong <0.01 >10.0 Approaching Infinity
  • 27. Nested Case-Control Studies Figure 3 Study Population TIME 1 YEARS TIME 2 Develop Disease Do Not Develop Disease CASES CONTROLS CASE-CONTROL STUDY Obtain interviews, bloods, urines, etc.
  • 28. A. Advantages of Nested Case-Control Studies 1. Possibility of recall bias is eliminated, since data on exposure are obtained before disease develops. 2. Exposure data are more likely to represent the pre-illness state since they are obtained years before clinical illness is diagnosed. 3. Costs are reduced compared to those of a prospective study, since laboratory tests need to be done only on specimens from subjects who are later chosen as cases or as controls.
  • 29.
  • 30. • A major limitation of cross-sectional surveys and case-control studies is difficulty in determining if exposure or risk factor preceded the disease or outcome. to overcome this problem ?
  • 32. WHAT IS COHORT • Ancient Roman military unit, A band of warriors. • Persons banded together. • Group of persons with a common statistical characteristic. [Latin] • E.g. age, birth date,
  • 33. Indication • When a good evidence of association between exposure and disease • When exposure is rare but incidence of disease in exposed is high • When follow up is easy and cohort is relatively stable • Ample funds available
  • 34. Elements of cohort study • Selection of study subjects • Obtaining data on exposure • Selection of comparison group • Follow up • Analysis
  • 35. Selection of subject • Group of people exposed to suspected cause • Eg cohort group who drink hard water (study cohort) • And cohort who don’t drink hard water(control cohort) • Comparison group are in built based on gradation of exposure
  • 36. • Cohort must be free from disease under study • Both cohort should be equally susceptible to the disease under study • Both cohort should be comparable • Diagnostic & eligibility criteria must be defined before study commences
  • 37. Characteristic of Cohort study  Longitudinal  Prospective studies  Forward looking study  Incidence study  starts with people free of disease  assesses exposure at “baseline”  assesses disease status at “follow-up”
  • 38.
  • 39. b+d Frame work of Cohort studies c c+d a a+b Total Yes Disease Status Yes No Exposure Status b d a+c N No Study cohort Comparison cohort
  • 40. Selection of study subjects • General population – Whole population in an area – A representative sample • Special group of population – Select group • occupation group / professional group (Dolls study ) – Exposure groups • Person having exposure to some physical, chemical or biological agent – e.g. X-ray exposure to radiologists
  • 41. Obtaining data on exposure • Personal interviews / mailed questionnaire • Reviews of records – Dose of drug, radiation, type of surgery etc • Medical examination or special test – Blood pressure, serum cholesterol • Environmental survey • By obtaining the data of exposure we can classify cohorts as – Exposed and non exposed and – By degree exposure we can sub classify cohorts
  • 42. Selection of comparison group • Internal comparison – Only one cohort involved in study – Sub classified and internal comparison done • External comparison – More than one cohort in the study for the purpose of comparison – e.g. Cohort of radiologist compared with ophthalmologists • Comparison with general population rates – If no comparison group is available we can compare the rates of study cohort with general population. – Cancer rate of uranium miners with cancer in general population
  • 43. Follow-up • To obtain data about outcome to be determined (morbidity or death) – Mailed questionnaire, telephone calls, personal interviews – Periodic medical examination – Reviewing records – Surveillance of death records – Follow up is the most critical part of the study • Some loss to follow up is inevitable due to death change of address, migration, change of occupation. • Loss to follow-up is one of the draw-back of the cohort study.
  • 44. ANALYSIS • Calculation of incidence rates among exposed and non exposed groups • Estimation of risk
  • 45. Incidence rates of outcome N d c b a Yes No Disease Status Yes No Exposure Status a+b c+d b+d a+c Total Study cohort Comparison cohort
  • 46. Incidence rate • Incidence among exposed = a a+b • Incidence among non-exposed = c c+d
  • 47. Estimation of risk • Relative Risk incidence of disease among exposed RR = ______________________________ Incidence of disease among non-exposed a/a+b = _________ c/c+d
  • 48. Estimation of Risk • Attributable Risk Incidence of disease among exposed – incidence of disease among non exposed AR = _______________________________ Incidence of disease among exposed a/a+b – c/c+d AR = _______________ a/a+b
  • 49. Smoking Lung cancer Total YES NO YES 70 6930 7000 NO 3 2997 3000 73 9927 10000 Find out RR and AR for above data
  • 50. • Incidence of lung cancer among smokers 70/7000 = 10 per 1000 • Incidence of lung cancer among non-smokers 3/3000 = 1 per thousand RR = 10 / 1 = 10 (lung cancer is 10 times more common among smokers than non smokers) AR = 10 – 1 / 10 X 100 = 90 % (90% of the cases of lung cancer among smokers are attributed to their habit of smoking)
  • 51. Types of Cohort Study • Prospective cohort study • Retrospective (historical) cohort study • Combination of Retrospective and Prospective cohort study.
  • 52. Cohort studies Strengths • We can find out incidence rate and risk • More than one disease related to single exposure • can establish cause - effect • good when exposure is rare • minimizes selection and information bias Weaknesses • losses to follow-up • often requires large sample • ineffective for rare diseases • long time to complete • expensive • Ethical issues
  • 53. Comparison between Case control & Cohort Case control • Proceed from effect to cause • Involves few subjects ,quick ,less expensive • Yields only estimate of relative risk by virtue of odds ratio • Sampling bias • Measuremnet bias Cohort • Proceed from cause to effect • Involves large no. prolong duration, expensive • Yield incidence rate,relative risk, attributable risk • No sampling bias • No information bias